Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peiqing Ye
Anti-Cd20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice
Frontiers in Immunology
Allergy
Immunology
Related publications
Factor VIII Associated With Lipidic Nanoparticles Retains Efficacy in the Presence of Anti-Factor VIII Antibodies in Hemophilia a Mice
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Immune Tolerance Induced by Platelet-Targeted Factor VIII Gene Therapy in Hemophilia a Mice Is CD4 T Cell-Mediated
Journal of Thrombosis and Haemostasis
Medicine
Hematology
B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Lentivirus-Mediated Platelet Gene Therapy of Murine Hemophilia a With Pre-Existing Anti-Factor VIII Immunity
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A
Thrombosis Research
Hematology
Chemoradiation Combined With Phosphatidylserine-Targeting Antibody Enhances Systemic Anti-Tumor Immune Responses
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Phosphatidylserine Reduces Immune Response Against Human Recombinant Factor VIII in Hemophilia a Mice by Regulation of Dendritic Cell Function
Clinical Immunology
Allergy
Immunology
Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology